These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1164819)

  • 21. Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effects.
    Bertilsson L; Nordin C; Otani K; Resul B; Scheinin M; Siwers B; Sjöqvist F
    Clin Pharmacol Ther; 1986 Sep; 40(3):261-7. PubMed ID: 3742932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nortriptyline metabolism in chronic renal failure: metabolite elimination.
    Dawling S; Lynn K; Rosser R; Braithwaite R
    Clin Pharmacol Ther; 1982 Sep; 32(3):322-9. PubMed ID: 7105623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics of nortriptyline in patients with chronic renal failure.
    Dawlilng S; Lynn K; Rosser R; Braithwaite R
    Br J Clin Pharmacol; 1981 Jul; 12(1):39-45. PubMed ID: 7248140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The kinetics of amitriptyline following single oral dose administration to man.
    Garland WA; Min BH; Birkett DJ
    Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):475-84. PubMed ID: 734227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of amitriptyline and one of its metabolites, nortriptyline, in rats: little contribution of considerable hepatic first-pass effect to low bioavailability of amitriptyline due to great intestinal first-pass effect.
    Bae SK; Yang KH; Aryal DK; Kim YG; Lee MG
    J Pharm Sci; 2009 Apr; 98(4):1587-601. PubMed ID: 18780336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nortriptyline pharmacokinetic parameters in depressed children and adolescents: preliminary data.
    Geller B; Cooper TB; Chestnut E; Abel AS; Anker JA
    J Clin Psychopharmacol; 1984 Oct; 4(5):265-9. PubMed ID: 6490962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition of quercetin in man after single oral and intravenous doses.
    Gugler R; Leschik M; Dengler HJ
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):229-34. PubMed ID: 1233267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. d-Propoxyphene kinetics after single oral and intravenous doses in man.
    Gram LF; Schou J; Way WL; Heltberg J; Bodin NO
    Clin Pharmacol Ther; 1979 Oct; 26(4):473-82. PubMed ID: 487695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative pharmacogenetics of nortriptyline: a novel approach.
    Kvist EE; Al-Shurbaji A; Dahl ML; Nordin C; Alván G; Ståhle L
    Clin Pharmacokinet; 2001; 40(11):869-77. PubMed ID: 11735606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and biological effects of nortriptyline in man.
    Sjöqvist F; Alexanderson B; Asberg M; Bertilsson L; Borgå O; Hamberger B; Tuck D
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():255-80. PubMed ID: 5316407
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of amitriptyline influenced by oral charcoal and urine pH.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):326-32. PubMed ID: 3015809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological disposition of verapamil in man.
    Schomerus M; Spiegelhalder B; Stieren B; Eichelbaum M
    Cardiovasc Res; 1976 Sep; 10(5):605-12. PubMed ID: 971476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma disappearance of nortriptyline in a newborn infant following placental transfer from an intoxicated mother: evidence for drug metabolism.
    Sjöqvist F; Bergfors PG; Borgå O; Lind M; Ygge H
    J Pediatr; 1972 Mar; 80(3):496-500. PubMed ID: 5017806
    [No Abstract]   [Full Text] [Related]  

  • 36. Nortriptyline kinetics in Hispanic and Anglo subjects.
    Gaviria M; Gil AA; Javaid JI
    J Clin Psychopharmacol; 1986 Aug; 6(4):227-31. PubMed ID: 3734142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism.
    von Bahr C; Steiner E; Koike Y; Gabrielsson J
    Clin Pharmacol Ther; 1998 Jul; 64(1):18-26. PubMed ID: 9695715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two prospective dosing methods for nortriptyline.
    Perry PJ; Browne JL; Alexander B; Tsuang MT; Sherman AD; Dunner FJ
    Clin Pharmacokinet; 1984; 9(6):555-63. PubMed ID: 6509862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer.
    Baker SD; Wirth M; Statkevich P; Reidenberg P; Alton K; Sartorius SE; Dugan M; Cutler D; Batra V; Grochow LB; Donehower RC; Rowinsky EK
    Clin Cancer Res; 1999 Feb; 5(2):309-17. PubMed ID: 10037179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amitriptyline pharmacokinetics. A crossover study with single doses of amitriptyline and nortriptyline.
    Burch JE; Hullin RP
    Psychopharmacology (Berl); 1981; 74(1):35-42. PubMed ID: 6791201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.